German Liver Cancer Study Group by AIO
The German Liver Cancer Study Group is an initiative led by investigators specialized in liver cancer, supported by AIO, in collaboration with the Frankfurt Institute for Clinical Cancer Research (IKF). The Group acts as a central hub, bringing together various active study groups for the conduct of multinational and intercontinental clinical trials under the guidance of AIO.
- Vision: Improving therapy outcomes for patients with liver tumors, including hepatocellular (HCC) and biliary tract (BTC) cancers, advancing cancer research and helping to provide answers to current and future important clinical questions in this area.
- Mission: Implementation of proof-of-concept studies, therapy optimization studies, translational biomarker research, precision oncology studies, evaluation of the health-related quality of life, and patient-reported outcomes in the field of hepato-biliary malignancies.
- Boards and Members The German Liver Cancer Study Group consist of eight founding members. The members from the four centers are already internationally recognized clinical trial leaders and/or have expertise relevant to achieving the study group's goals.